---
schema_version: "secwatch.filing_event.v1"
accession: "0001562762-25-000166"
form_type: "8-K"
ticker: "GMED"
cik: "0001237831"
company_name: "GLOBUS MEDICAL INC"
filed_at: "2025-07-21T23:59:59+00:00"
generated_at: "2026-05-18T04:57:43.995444+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Globus Medical CEO Scavilla resigns; Pfeil named CEO; preliminary Q2 sales $745.3M (+18% YoY)

## Summary
- Daniel Scavilla resigned as President and CEO effective July 18, 2025 to pursue another opportunity; no disagreement cited.
- Keith Pfeil, formerly COO/CFO, appointed President and CEO effective July 18, 2025; also joins Board.
- Kyle Kline appointed CFO effective July 18, 2025; previously SVP of Finance.
- Preliminary Q2 2025 sales ~$745.3M, up 18.4% as reported; base business ex-Nevro up 4.8% day-adjusted.
- Full-year 2025 guidance reaffirmed: revenue $2.80–$2.90B, non-GAAP EPS $3.00–$3.30.

## SEC filing metadata
- accession: 0001562762-25-000166
- form_type: 8-K
- ticker: GMED
- cik: 0001237831
- company_name: GLOBUS MEDICAL INC
- filed_at: 2025-07-21T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1237831/000156276225000166/0001562762-25-000166-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1237831/000156276225000166/gmed-20250718x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001562762-25-000166
- JSON: https://secwatch.observer/filing/0001562762-25-000166.json
- Plain text: https://secwatch.observer/filing/0001562762-25-000166.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.